Andrew Regan - 24 Mar 2026 Form 4 Insider Report for CDT Equity Inc. (CDT)

Reporting relationship: Chief Executive Officer, Director
Issuer ticker: CDT
Reported as of: 24 Mar 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 14 May 2026, 08:42:42 UTC
Prior SEC filing: 22 Dec 2025
Source filing: View source filing
Reporting owner signature: /s/ Andrew Regan

Key filing fact

Andrew Regan filed Form 4 for CDT Equity Inc. (CDT) on 14 May 2026.

Key facts

This page summarizes Andrew Regan's Form 4 filing for CDT Equity Inc. (CDT).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 14 May 2026, 08:42.

Change

Previous filing in this sequence was filed on 22 Dec 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001991325 Primary reporting owner

Regan Andrew

Relationship: Chief Executive Officer, Director
Address: 4851 TAMIAMI TRAIL NORTH, SUITE 200, NAPLES
Signature: /s/ Andrew Regan
Signature date: 14 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CDT transaction

Common Stock

Award

Transaction value
Shares: +147,401
Change %: +1639%
Price
Shares after: 156,393
Date: 24 Mar 2026
Ownership: By Corvus Capital Ltd.
Footnotes: F1, F2, F3, F6

CDT transaction

Common Stock

Award

Transaction value
Shares: +100,000
Change %: +64%
Price: $1.90^*
Shares after: 256,393
Date: 13 May 2026
Ownership: By Corvus Capital Ltd.
Footnotes: F3, F4, F6

CDT holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 5,600
Date: 24 Mar 2026
Ownership: Direct

CDT holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 773
Date: 24 Mar 2026
Ownership: By Manoira Corporation
Footnotes: F5, F6

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CDT transaction Derivative

Pre-Funded Warrants

Conversion of derivative security

Transaction value
Shares: -147,401
Change %: -100%
Price: $0.000100^*
Shares after: 0
Date: 24 Mar 2026
Ownership: By Corvus Capital Ltd.
Underlying class: Common Stock
Underlying amount: 147,401
Exercise price: $0.000100
Footnotes: F1, F2, F3, F6, F7

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 7 footnotes

Footnote F1

On March 26, 2026, CDT Equity Inc. (the "Company") effected a 1-for-25 reverse stock split (the "Reverse Stock Split") of the Company's outstanding shares of common stock, par value $0.0001 per share (the "Common Stock"). The number of shares of Common Stock and prices reported on this Form 4 have been adjusted to reflect the Reverse Stock Split. Corvus ceased to be a 10% holder as of February 19, 2026.

Footnote F2

On March 24, 2026, Corvus Capital Limited ("Corvus") exercised all its pre-funded warrants (the "Pre-Funded Warrants") via cashless exercise for 147,401 shares of Common Stock.

Footnote F3

These shares of Common Stock are owned of record by Corvus.

Footnote F4

On May 13, 2026, Corvus purchased a total of 100,000 shares of Common Stock in the open market at a price per share of $1.90 for total cash consideration of $190,000.

Footnote F5

These shares of Common Stock are owned of record by Manoira Corporation ("Manoira").

Footnote F6

Corvus is the owner of 99.0% of the equity interests of Manoira and, therefore, may also be deemed to beneficially own the shares of Common Stock held of record by Manoira. Dr. Regan is the sole director of Manoira and the Chief Executive Officer and sole shareholder of Corvus. By virtue of these relationships, Dr. Regan may be deemed to beneficially own the shares of Common Stock held of record by Manoira and Corvus. Each of Corvus and Dr. Regan disclaims any such beneficial ownership, except to the extent of its or his pecuniary interest therein.

Footnote F7

The Pre-Funded Warrants have been exercised in full.